These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 26757599

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. TRAP-induced platelet aggregation is enhanced in cardiovascular patients receiving dabigatran.
    Olivier CB, Weik P, Meyer M, Weber S, Anto-Michel N, Diehl P, Zhou Q, Geisen U, Bode C, Moser M.
    Thromb Res; 2016 Feb; 138():63-68. PubMed ID: 26610745
    [Abstract] [Full Text] [Related]

  • 3. Dabigatran-related platelet thrombin response during triple anti-thrombotic therapy: A matter of time?
    Witkowski M, Steffens D, Hassanein A, Witkowski M, Kränkel N, Doerner A, Friebel J, Landmesser U, Rauch U.
    Thromb Res; 2017 Jan; 149():62-63. PubMed ID: 27907813
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dabigatran reduces thrombin-induced platelet aggregation and activation in a dose-dependent manner.
    Vinholt PJ, Nielsen C, Söderström AC, Brandes A, Nybo M.
    J Thromb Thrombolysis; 2017 Aug; 44(2):216-222. PubMed ID: 28580515
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dabigatran affects thrombin-dependent platelet aggregation after a week-long therapy.
    Sokol J, Nehaj F, Ivankova J, Mokan M, Mokan M, Stasko J.
    Scand Cardiovasc J; 2018 Aug; 52(4):227-231. PubMed ID: 29842807
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
    Aoki T, Tomiyama Y, Honda S, Senzaki K, Tanaka A, Okubo M, Takahashi F, Takasugi H, Seki J.
    Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
    [Abstract] [Full Text] [Related]

  • 12. Dabigatran (Pradaxa(®)): surgeon's friend or foe?
    Syyed N, Ansell M, Sood V.
    Br Dent J; 2014 Dec 05; 217(11):623-6. PubMed ID: 25476635
    [Abstract] [Full Text] [Related]

  • 13. Dabigatran enhances platelet reactivity and platelet thrombin receptor expression in patients with atrial fibrillation.
    Achilles A, Mohring A, Dannenberg L, Grandoch M, Hohlfeld T, Fischer JW, Levkau B, Kelm M, Zeus T, Polzin A.
    J Thromb Haemost; 2017 Mar 05; 15(3):473-476. PubMed ID: 27992120
    [Abstract] [Full Text] [Related]

  • 14. Design, Synthesis, and Biological Evaluation of Dabigatran Etexilate Mimics, a Novel Class of Thrombin Inhibitors.
    Wang S, Dai P, Xu Y, Chen Q, Zhu Q, Gong G.
    Arch Pharm (Weinheim); 2015 Aug 05; 348(8):595-605. PubMed ID: 26120827
    [Abstract] [Full Text] [Related]

  • 15. Design, synthesis and structural exploration of novel fluorinated dabigatran derivatives as direct thrombin inhibitors.
    Li ML, Ren YJ, Dong MH, Ren WX.
    Eur J Med Chem; 2015 Aug 05; 96():122-38. PubMed ID: 25874337
    [Abstract] [Full Text] [Related]

  • 16. Fibrin formation by staphylothrombin facilitates Staphylococcus aureus-induced platelet aggregation.
    Vanassche T, Kauskot A, Verhaegen J, Peetermans WE, van Ryn J, Schneewind O, Hoylaerts MF, Verhamme P.
    Thromb Haemost; 2012 Jun 05; 107(6):1107-21. PubMed ID: 22437005
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The influence of direct thrombin inhibitors on the formation of platelet-leukocyte aggregates and tissue factor expression.
    Christersson C, Johnell M, Siegbahn A.
    Thromb Res; 2010 Oct 05; 126(4):e327-33. PubMed ID: 20451956
    [Abstract] [Full Text] [Related]

  • 20. Newborn platelets: lower levels of protease-activated receptors cause hypoaggregability to thrombin.
    Schlagenhauf A, Schweintzger S, Birner-Gruenberger R, Leschnik B, Muntean W.
    Platelets; 2010 Oct 05; 21(8):641-7. PubMed ID: 20807173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.